CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-08 | Kumar Rashmi Director | Sale 10b5-1 | −15,000 | $4.46 | $67K | 171,889 |
| 2026-06-04 | Kumar Rashmi Director | Grant or award | +59,701 | 186,889 | ||
| 2025-06-05 | Kumar Rashmi Director | Grant or award | +49,796 | 127,188 | ||
| 2024-08-19 | Kumar Rashmi Director | Sale 10b5-1 | −7,500 | $28.01 | $210K | 77,392 |
| 2024-06-06 | Kumar Rashmi Director | Grant or award | +15,695 | 84,892 | ||
| 2023-06-01 | Kumar Rashmi Director | Grant or award | +15,151 | 69,197 | ||
| 2022-06-02 | Kumar Rashmi Director | Grant or award | +17,275 | 54,046 | ||
| 2021-06-03 | Kumar Rashmi Director | Grant or award | +12,848 | 36,771 | ||
| 2020-09-17 | Kumar Rashmi Director | Grant or award | +23,923 | 23,923 |
Page 1 of 1 · 9 trades